The Motley Fool has <a href="https://www.fool.com/investing/2025/04/15/want-to-invest-in-quantum-computing-3-stocks-that/">spotlighted</a> three stocks for investors interested in quantum computing. The picks vary in size — from the small-cap D-Wave to tech giant IBM — but the investing news and analysis outlet believes all three could deliver solid long-term returns.

The Motley Fool spotlights three quantum computing stocks

Shares of Longevity Health Holdings, a <a href="https://last10k.com/sec-filings/xage#item_1_business:~:text=%D1%83%20%D0%BD%D0%B0%D1%81%20%D0%B5%D1%81%D1%82%D1%8C%20%D0%B4%D0%B2%D0%B5%20%D0%BA%D0%BE%D1%81%D0%BC%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5%20%D0%BB%D0%B8%D0%BD%D0%B8%D0%B8%20%D0%BF%D1%80%D0%BE%D0%B4%D1%83%D0%BA%D1%82%D0%BE%D0%B2%2C">maker</a> of regenerative skin care products, <a href="https://finance.yahoo.com/chart/XAGE#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">fell</a> nearly 13% yesterday, April 15, following a 67% surge the previous day. The rally was triggered by an <a href="https://www.globenewswire.com/news-release/2025/04/14/3060883/0/en/Longevity-Health-Holdings-Announces-Execution-of-Merger-Agreement-With-20-20-Biolabs.html">announced</a> merger with diagnostic test provider 20/20 BioLabs. Noble Capital Markets <a href="https://www.channelchek.com/news-channel/longevity-health-merges-with-20-20-biolabs-in-bid-to-redefine-healthy-aging">points out</a> that this is neither Longevity’s first nor likely last deal as it positions itself as a “unique micro-cap consolidator” in the rapidly growing longevity space.

Longevity Health slips after big rally triggered by merger announcement


Quotes on Lisata Therapeutics, a pharmaceutical company developing therapies to combat tumors, <a href="https://finance.yahoo.com/quote/LSTA/">gained</a> more than 10% yesterday, April 15, after it announced a partnership with one of the largest industry manufacturers, Catalent, to evaluate the efficacy of a promising Lisata therapy. Since December, Catalent has been owned by Novo Holdings, the controlling shareholder of Denmark’s Novo Nordisk, a global leader in weight-loss medications.

Biotech small cap Lisata Therapeutics jumps 10% on partnership with Novo subsidiary


SolarBank Corporation, a Canada-based but U.S.-listed micro-cap developer of renewable and clean energy projects, is significantly undervalued, Zacks Small-Cap Research (Zacks SCR) <a href="https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_04112025_SUUN_Lantier.pdf">believes</a>, with the shares worth more than double their current market quotes. Thanks to a sizable project pipeline and continued demand for solar energy, even the shift in U.S. federal energy policy under Trump is unlikely to derail SolarBank’s growth, Zacks SCR <a href="https://scr.zacks.com/news/news-details/2025/SUUN-The-future-is-bright-Initiating-coverage-of-an-emerging-solar-developer-and-power-producer-article/default.aspx">argues</a>.

Zacks thinks micro cap SolarBank could double in price


Shares of Verve Therapeutics, a biotech small cap specializing in gene-editing medicines to treat cardiovascular disease, <a href="https://finance.yahoo.com/quote/VERV/">surged</a> more than 26% yesterday, April 14, after the company reported positive early trial results for its therapy for high cholesterol.

Verve Therapeutics reports good early test results for cholesterol drug, shares soar

The Motley Fool has <a href="https://www.fool.com/investing/2025/04/13/the-smartest-renewable-energy-stocks-to-buy-with/">highlighted</a> three small-cap stocks in the renewable energy sector for investors to buy right now. All three are speculative investments but could grow if the companies scale up their businesses. Moreover, these stocks have not been immune to the recent slump triggered by President Trump’s pro-fossil fuel <a href="https://oninvest.com/article/tramp-protiv-zelenoj-energetiki-cto-delat-investoram-v-small-cap-kompanii">stance</a>, which, according to the Motley Fool, might represent a “golden buying opportunity” for long-term investors.

The Motley Fool spotlights three ‘green’ small caps to buy on the dip


Noble Capital Markets <a href="https://www.channelchek.com/news-channel/saga-communications-sga-is-it-time-to-buy-the-stock">thinks</a> now may be the right time for investors to take a look at small-cap broadcast company Saga Communications, which operates more than a hundred radio stations globally. The stock has <a href="https://finance.yahoo.com/quote/SGA/">dropped</a> nearly 50% over the last year, largely due to macroeconomic uncertainty weighing on ad revenues. However, Noble believes the company can now get back to focusing on strategy execution.

Noble cuts target price, maintains ‘outperform’ on Saga Coms. as shares slide

Last week, small caps were the worst-performing segment of the U.S. market, while volatility reached staggering levels — 3.5 times the five-year average. Here's a recap of what happened in the space between April 7 and April 11, and what to expect in the week ahead.

Small-cap recap/preview: Underperformance, extreme volatility, 30 firms to report

Data

Quotes on Byrna Technologies, a smaller company producing less-lethal weapons, <a href="https://finance.yahoo.com/quote/BYRN/">jumped</a> more than 9% yesterday, April 10, after the company <a href="https://ir.byrna.com/news-events/press-releases/detail/219/byrna-technologies-fiscal-first-quarter-2025-results">reported</a> 57% year-over-year growth in revenue and a staggering 100-fold increase in net income for the first quarter. The boost came from expanded U.S. manufacturing and the launch of new retail distribution channels.

Less-lethal weapons maker Byrna reports 100-fold increase in net income, shares soar


The board of directors of DayDayCook (DDC), a Hong Kong-based but U.S.-listed provider of ready-to-eat meals for Gen Z, has approved a 1-for-25 reverse stock split. The company hopes this will allow its shares to resume trading on the New York Stock Exchange, where they were halted following a steep drop in the share price amid the tariff-induced global market selloff.

Food company DDC to do reverse stock split after NYSE trading halt


Lakeland Industries, a smaller company that makes safety apparel, reported its fiscal-2025 fourth-quarter and full-year results yesterday, April 9, and <a href="https://feeds.issuerdirect.com/news-release.html?newsid=6095592196070770&amp;symbol=LAKE">announced</a> a global production overhaul to mitigate the impact of potential trade wars. Following a year of aggressive acquisitions globally, the company now finds itself at the center of intensifying trade tensions.

Safety apparel maker Lakeland reshuffles global production amid trade tensions


The Royce Small-Cap Opportunity Fund, which — like all funds created by the firm of <a href="https://oninvest.com/article/kak-investirovat-v-small-cap-pat-covetov-ot-caka-rojsa-legendy-uoll-strit">Wall Street legend</a> Chuck Royce — specializes in small caps, has been one of the investment vehicles hit hardest by Trump’s tariffs, according to the rating agency Morningstar.

Royce Small-Cap Opportunity Fund among biggest tariff losers

Freedom Broker has put out a short-term investment idea to buy shares of Autolus Therapeutics, a UK-based and U.S.-listed small-cap developer of gene therapies for cancer and immune disorders. The company is flush with cash, has one regulator-approved drug, and is expected to release early-stage data on another therapy soon. If the results are favorable, Freedom Broker believes the stock could soar.